How glucagon-like peptide-1 receptor activators affect muscle mass

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Maciej Banach has received grant(s)/research support from Amgen, Daiichi-Sankyo, Mylan/Viatris, Sanofi and (last 36 months) has served as a consultant and/or received speaker’s fees from Adamed, Amgen, Exceed Pharma, Daiichi-Sankyo, Esperion, Kogen, KRKA, Lilly, MSD, Mylan/Viatris, NewAmsterdam Pharma, Novartis, Novo-Nordisk, Polpharma, Sanofi, Teva and Zentiva.